SW – Smurfit WestRock plc

SW — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

4.68

Margin Of Safety %

Put/Call OI Ratio

0.41

EPS Next Q Diff

0.05

EPS Last/This Y

0.1

EPS This/Next Y

1.78

Price

42.36

Target Price

53.66

Analyst Recom

1.07

Performance Q

-11.41

Upside

-26.4%

Beta

0.94

Ticker: SW

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	SW	41.23	0.30	1.10	19582
2026-10-16	SW	41.15	0.27	0.04	19249
2026-10-19	SW	40.85	0.28	0.09	9927
2026-10-20	SW	41.19	0.28	0.36	10220
2026-10-21	SW	41.47	0.27	0.31	10320
2026-10-22	SW	42.43	0.28	0.01	10360
2026-10-23	SW	41.84	0.25	0.87	11047
2026-10-26	SW	42.23	0.26	2.09	11116
2026-10-27	SW	42.59	0.27	2.50	11205
2026-10-28	SW	40.35	0.27	1.23	11181
2026-10-29	SW	42.52	0.32	0.04	11983
2026-10-30	SW	42.87	0.31	0.12	12197
2026-11-02	SW	43.38	0.32	0.63	12147
2026-11-03	SW	43.42	0.32	0.14	12209
2026-11-04	SW	45.21	0.32	0.43	12260
2026-11-05	SW	44.51	0.33	0.59	12877
2026-11-06	SW	44.08	0.33	0.93	12880
2026-11-09	SW	44.21	0.39	0.16	14937
2026-11-10	SW	44.35	0.39	0.36	14969
2026-11-11	SW	44.01	0.39	4.05	14983
2026-11-12	SW	43.19	0.40	0.39	15057
2026-11-13	SW	42.34	0.41	0.92	14820
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	SW	41.24	0.2	1639.5	1.72
2026-10-16	SW	41.15	0.2	1651.1	1.72
2026-10-19	SW	40.84	-0.2	1643.0	1.72
2026-10-20	SW	40.84	-0.2	1643.0	1.72
2026-10-21	SW	41.19	-0.2	1659.5	1.72
2026-10-22	SW	42.42	-0.2	1719.0	1.71
2026-10-23	SW	41.85	-0.2	1647.3	1.71
2026-10-26	SW	42.23	-1.0	1703.3	1.72
2026-10-27	SW	42.58	-1.0	1699.8	1.72
2026-10-28	SW	40.35	-1.0	1585.3	1.72
2026-10-29	SW	42.52	-1.0	1576.2	1.72
2026-10-30	SW	43.09	149.3	1485.9	1.63
2026-11-02	SW	43.38	149.3	1483.7	1.63
2026-11-03	SW	43.42	80.8	1495.8	1.47
2026-11-04	SW	45.21	80.8	1556.8	1.47
2026-11-05	SW	44.52	80.8	1622.7	1.47
2026-11-06	SW	44.08	80.8	1637.7	1.44
2026-11-09	SW	44.20	80.8	1670.7	1.44
2026-11-10	SW	44.35	80.8	1671.5	1.44
2026-11-11	SW	44.04	80.8	1626.4	1.44
2026-11-12	SW	43.10	98.2	1619.9	1.44
2026-11-13	SW	42.36	98.2	1610.3	1.44
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	SW	0.00	1.97	5.06
2026-10-16	SW	0.00	1.97	5.06
2026-10-19	SW	0.00	2.56	5.06
2026-10-20	SW	0.00	2.56	5.06
2026-10-21	SW	0.00	2.56	5.06
2026-10-22	SW	0.00	2.56	5.06
2026-10-23	SW	0.00	2.56	5.06
2026-10-26	SW	0.00	1.38	5.06
2026-10-27	SW	0.00	1.38	4.45
2026-10-28	SW	0.00	1.38	4.45
2026-10-29	SW	0.00	1.38	4.45
2026-10-30	SW	0.00	1.38	4.45
2026-11-02	SW	0.00	1.28	4.45
2026-11-03	SW	0.00	1.28	4.45
2026-11-05	SW	0.00	1.28	4.45
2026-11-06	SW	0.00	1.28	4.45
2026-11-09	SW	0.00	1.02	4.45
2026-11-10	SW	0.00	1.02	4.45
2026-11-11	SW	0.00	1.02	4.68
2026-11-12	SW	0.00	1.02	4.68
2026-11-13	SW	0.00	1.02	4.68
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.45

Avg. EPS Est. Current Quarter

0.56

Avg. EPS Est. Next Quarter

0.5

Insider Transactions

Institutional Transactions

1.02

Beta

0.94

Average Sales Estimate Current Quarter

8046

Average Sales Estimate Next Quarter

8381

Fair Value

53.5

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

27.4

Max Drawdown 5-Year %

-53.3

Target Price

53.66

P/E

47.42

Forward P/E

13.22

PEG

0.6

P/S

0.7

P/B

1.23

P/Free Cash Flow

25.74

EPS

0.89

Average EPS Est. Cur. Y

1.44

EPS Next Y. (Est.)

3.22

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

1.5

Relative Volume

0.75

Return on Equity vs Sector %

-17.6

Return on Equity vs Industry %

-0.1

EPS 1 7Days Diff

-0.3

EPS 1 30Days Diff

-0.37

EBIT Estimation

1610.3

◆ SW Consumer Cyclical

$42.35

📉

Swing / Pullback

Buy the dip on strong trends

WATCH

Trend

12/20

Pullback

9/25

Volume

9/15

Valuation

20/20

TP/AR

2/10

Options

6/10

RSI

Range 1M

46.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

4/25

Growth

12/30

Estimates

4/20

Inst/Vol

4/15

Options

6/10

EPS Yr

-7.6%

EPS NY

69.2%

52W%

48.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +96.3% upside

Quality

3/30

Valuation

24/30

Growth

8/25

Stability

5/10

LT Trend

4/5

Upside

+96.3%

Quality

MoS

26%

SW — P/E HistoricalPackaging & Containers

Smurfit WestRock plc

Sector: Consumer Cyclical

Industry: Packaging & Containers

Employees: 96000

Smurfit Westrock Plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in North America, South America, Europe, Asia, Africa, Australia, and internationally. The company produces containerboard and paperboard; packaging of corrugated containers; consumer packaging; and offers solid board, kraft paper, and graphic board, as well as other packaging products, such as solidboard packaging, paper sacks and bag-in-box. It produces linerboard and corrugated medium and paperboard; and other paper-based packaging, such as folding cartons, inserts, labels and displays. The company primarily serves food and beverage, healthcare, beauty and personal care, garden, consumer goods, industrial, and foodservice markets. It markets its products through its own sales force, independent sales representatives, and independent distributors. Smurfit Westrock Plc was founded in 1934 and is headquartered in Dublin, Ireland.

Latest News

—

Caricamento notizie per SW…

stock quote shares SW – Smurfit WestRock plc Stock Price stock today

news today SW – Smurfit WestRock plc stock forecast ,stock prediction 2023 2024 2025

marketwatch SW – Smurfit WestRock plc yahoo finance google finance

stock history SW – Smurfit WestRock plc invest stock market

stock prices SW premarket after hours

ticker SW fair value insiders trading

MURA – Mural Oncology plc

MURA — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.66

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

2.04

Target Price

Analyst Recom

Performance Q

-1.45

Upside

N/A

Beta

2.88

Ticker: MURA

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	MURA	2.04	N/A	N/A	0
2026-10-16	MURA	2.04	N/A	N/A	0
2026-10-19	MURA	2.04	N/A	N/A	0
2026-10-20	MURA	2.04	N/A	N/A	0
2026-10-21	MURA	2.04	N/A	N/A	0
2026-10-22	MURA	2.04	N/A	N/A	0
2026-10-23	MURA	2.04	N/A	N/A	0
2026-10-26	MURA	2.04	N/A	N/A	0
2026-10-27	MURA	2.04	N/A	N/A	0
2026-10-28	MURA	2.04	N/A	N/A	0
2026-10-29	MURA	2.04	N/A	N/A	0
2026-10-30	MURA	2.04	N/A	N/A	0
2026-11-02	MURA	2.04	N/A	N/A	0
2026-11-03	MURA	2.04	N/A	N/A	0
2026-11-04	MURA	2.04	N/A	N/A	0
2026-11-05	MURA	2.04	N/A	N/A	0
2026-11-06	MURA	2.04	N/A	N/A	0
2026-11-09	MURA	2.04	N/A	N/A	0
2026-11-10	MURA	2.04	N/A	N/A	0
2026-11-11	MURA	2.04	N/A	N/A	0
2026-11-12	MURA	2.04	N/A	N/A	0
2026-11-13	MURA	2.04	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.37

Avg. EPS Est. Next Quarter

Insider Transactions

-2.62

Institutional Transactions

-16.45

Beta

2.88

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

0.64

P/Free Cash Flow

EPS

-6.93

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

-0.39

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

-242.8

Return on Equity vs Industry %

-227.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

No data found for MURA

MURA — P/E HistoricalDrug Manufacturers - Specialty & Generic

Sector:

Industry:

Employees:

MURA

Latest News

—

Caricamento notizie per MURA…

stock quote shares MURA – Mural Oncology plc Stock Price stock today

news today MURA – Mural Oncology plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MURA – Mural Oncology plc yahoo finance google finance

stock history MURA – Mural Oncology plc invest stock market

stock prices MURA premarket after hours

ticker MURA fair value insiders trading

MDT – Medtronic Plc

MDT — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

1.8

Margin Of Safety %

Put/Call OI Ratio

0.66

EPS Next Q Diff

-0.03

EPS Last/This Y

0.45

EPS This/Next Y

0.43

Price

102.86

Target Price

104.27

Analyst Recom

1.84

Performance Q

13.54

Upside

-48.7%

Beta

0.56

Ticker: MDT

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	MDT	95.47	0.60	0.49	339317
2026-10-16	MDT	94.76	0.50	0.63	318924
2026-10-19	MDT	92.79	0.74	0.54	183445
2026-10-20	MDT	94.64	0.73	0.64	189239
2026-10-21	MDT	93.04	0.72	0.80	195800
2026-10-22	MDT	96.58	0.72	0.73	197835
2026-10-23	MDT	95.42	0.73	0.71	199857
2026-10-26	MDT	94.79	0.75	0.75	193594
2026-10-27	MDT	93.93	0.75	0.54	196986
2026-10-28	MDT	94.8	0.76	0.11	196683
2026-10-29	MDT	97.1	0.71	0.20	207356
2026-10-30	MDT	96.56	0.69	2.24	212146
2026-11-02	MDT	99.29	0.73	0.36	200509
2026-11-03	MDT	98.89	0.72	0.80	205781
2026-11-04	MDT	105.02	0.71	0.38	207879
2026-11-05	MDT	104.85	0.69	0.64	219262
2026-11-06	MDT	101.82	0.70	1.95	222233
2026-11-09	MDT	102.79	0.68	0.39	214580
2026-11-10	MDT	101.61	0.68	0.39	216722
2026-11-11	MDT	101.4	0.67	0.36	220285
2026-11-12	MDT	100.97	0.66	0.33	221511
2026-11-13	MDT	102.89	0.66	0.40	223869
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	MDT	95.47	-2.0	-274.8	5.98
2026-10-16	MDT	94.75	-2.0	-474.2	5.98
2026-10-19	MDT	92.74	-2.0	-556.6	5.98
2026-10-20	MDT	92.74	-2.0	-556.6	5.98
2026-10-21	MDT	94.67	-2.0	-310.2	5.98
2026-10-22	MDT	96.58	-2.0	-205.6	5.98
2026-10-23	MDT	95.41	-2.0	-502.6	5.98
2026-10-26	MDT	94.79	-2.0	-469.5	5.98
2026-10-27	MDT	93.93	-2.0	-484.4	5.98
2026-10-28	MDT	94.80	-2.0	-377.5	5.98
2026-10-29	MDT	97.10	-2.0	-286.1	5.98
2026-10-30	MDT	96.54	-2.0	-465.9	5.98
2026-11-02	MDT	99.30	-2.0	-261.3	5.98
2026-11-03	MDT	98.89	-2.0	-286.5	5.98
2026-11-04	MDT	105.04	-2.0	-59.9	5.98
2026-11-05	MDT	104.85	-2.0	-437.3	5.98
2026-11-06	MDT	101.73	-2.0	-609.1	5.98
2026-11-09	MDT	102.80	-2.0	-372.3	5.98
2026-11-10	MDT	101.61	-2.0	-499.8	5.98
2026-11-11	MDT	101.63	-2.0	-428.7	5.98
2026-11-12	MDT	101.00	-2.0	-466.9	5.98
2026-11-13	MDT	102.86	-2.0	-320.4	5.98
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	MDT	-0.76	-1.59	3.13
2026-10-16	MDT	-0.76	-1.59	3.13
2026-10-19	MDT	-5.67	-1.62	3.13
2026-10-20	MDT	-5.67	-1.62	3.13
2026-10-21	MDT	-5.67	-1.62	3.13
2026-10-22	MDT	-5.67	-1.62	3.13
2026-10-23	MDT	-5.67	-1.62	3.13
2026-10-26	MDT	-5.67	-1.94	3.13
2026-10-27	MDT	-5.67	-1.94	10.88
2026-10-28	MDT	-5.67	-1.94	10.88
2026-10-29	MDT	-5.67	-1.94	10.88
2026-10-30	MDT	-5.67	-1.94	10.88
2026-11-02	MDT	-5.67	-1.99	10.88
2026-11-03	MDT	-5.67	-1.99	10.88
2026-11-05	MDT	-5.67	-1.99	10.88
2026-11-06	MDT	-5.67	-1.99	10.88
2026-11-09	MDT	-5.67	-0.06	10.88
2026-11-10	MDT	-5.67	-0.06	10.88
2026-11-11	MDT	-5.67	-0.06	1.80
2026-11-12	MDT	-5.67	-0.06	1.80
2026-11-13	MDT	-5.67	-0.06	1.80
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

1.45

Avg. EPS Est. Current Quarter

1.33

Avg. EPS Est. Next Quarter

1.42

Insider Transactions

-5.67

Institutional Transactions

-0.06

Beta

0.56

Average Sales Estimate Current Quarter

9479

Average Sales Estimate Next Quarter

9522

Fair Value

103

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

14.2

Max Drawdown 5-Year %

-38.1

Target Price

104.27

P/E

25.32

Forward P/E

16.09

PEG

2.08

P/S

3.51

P/B

2.62

P/Free Cash Flow

21.46

EPS

4.06

Average EPS Est. Cur. Y

5.98

EPS Next Y. (Est.)

6.41

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13.93

Relative Volume

0.31

Return on Equity vs Sector %

-16

Return on Equity vs Industry %

-0.4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-320.4

◆ MDT Healthcare

$102.86

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

12/20

Pullback

8/25

Volume

8/15

Valuation

8/20

TP/AR

1/10

Options

4/10

RSI

63.7

Range 1M

76.6%

Sup Dist

2.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

11/25

Growth

14/30

Estimates

6/20

Inst/Vol

3/15

Options

7/10

EPS Yr

8.1%

EPS NY

52W%

89.6%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -9.2% upside

Quality

14/30

Valuation

2/30

Growth

10/25

Stability

5/10

LT Trend

4/5

Upside

-9.2%

Quality

MoS

MDT — P/E HistoricalMedical Devices

Medtronic plc.

Sector: Healthcare

Industry: Medical Devices

Employees: 95000

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

MDT

Latest News

—

Caricamento notizie per MDT…

stock quote shares MDT – Medtronic Plc Stock Price stock today

news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch MDT – Medtronic Plc yahoo finance google finance

stock history MDT – Medtronic Plc invest stock market

stock prices MDT premarket after hours

ticker MDT fair value insiders trading

ITRM – Iterum Therapeutics Plc

ITRM — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

5.85

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.1

EPS Last/This Y

EPS This/Next Y

0.35

Price

0.03

Target Price

Analyst Recom

Performance Q

-91.64

Upside

N/A

Beta

3.42

Ticker: ITRM

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	ITRM	0.03	N/A	N/A	0
2026-10-16	ITRM	0.03	N/A	N/A	0
2026-10-19	ITRM	0.03	N/A	N/A	0
2026-10-20	ITRM	0.03	N/A	N/A	0
2026-10-21	ITRM	0.03	N/A	N/A	0
2026-10-22	ITRM	0.03	N/A	N/A	0
2026-10-23	ITRM	0.03	N/A	N/A	0
2026-10-26	ITRM	0.03	N/A	N/A	0
2026-10-27	ITRM	0.03	N/A	N/A	0
2026-10-28	ITRM	0.03	N/A	N/A	0
2026-10-29	ITRM	0.03	N/A	N/A	0
2026-10-30	ITRM	0.03	N/A	N/A	0
2026-11-02	ITRM	0.03	N/A	N/A	0
2026-11-03	ITRM	0.03	N/A	N/A	0
2026-11-04	ITRM	0.03	N/A	N/A	0
2026-11-05	ITRM	0.03	N/A	N/A	0
2026-11-06	ITRM	0.03	N/A	N/A	0
2026-11-09	ITRM	0.03	N/A	N/A	0
2026-11-10	ITRM	0.03	N/A	N/A	0
2026-11-11	ITRM	0.03	N/A	N/A	0
2026-11-12	ITRM	0.03	N/A	N/A	0
2026-11-13	ITRM	0.03	N/A	N/A	0
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

Last Quarter Act. EPS

-0.2

Avg. EPS Est. Current Quarter

-0.14

Avg. EPS Est. Next Quarter

-0.1

Insider Transactions

1.46

Institutional Transactions

Beta

3.42

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

99.9

Max Drawdown 5-Year %

-99.9

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

-0.72

Average EPS Est. Cur. Y

-0.66

EPS Next Y. (Est.)

-0.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

337.7

Return on Equity vs Industry %

354.2

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.33

EBIT Estimation

9.2

No data found for ITRM

ITRM — P/E HistoricalBiotechnology

ITRM

Latest News

—

Caricamento notizie per ITRM…

stock quote shares ITRM – Iterum Therapeutics Plc Stock Price stock today

news today ITRM – Iterum Therapeutics Plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ITRM – Iterum Therapeutics Plc yahoo finance google finance

stock history ITRM – Iterum Therapeutics Plc invest stock market

stock prices ITRM premarket after hours

ticker ITRM fair value insiders trading

AMRN – Amarin Corp ADR

AMRN — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.55

Margin Of Safety %

-16

Put/Call OI Ratio

0.19

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

11.44

Target Price

Analyst Recom

Performance Q

-18.77

Upside

-383.0%

Beta

0.79

Ticker: AMRN

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	AMRN	11.61	0.36	0.00	3040
2026-10-16	AMRN	11.32	0.29	0.08	2945
2026-10-19	AMRN	11.53	0.19	0.00	2668
2026-10-20	AMRN	11.53	0.19	0.00	2718
2026-10-21	AMRN	11.54	0.18	0.01	2841
2026-10-22	AMRN	11.59	0.17	0.11	2894
2026-10-23	AMRN	11.81	0.17	0.18	2910
2026-10-26	AMRN	12.11	0.17	1.14	3028
2026-10-27	AMRN	11.97	0.18	0.00	3057
2026-10-28	AMRN	12.7	0.17	0.12	3100
2026-10-29	AMRN	12.81	0.17	0.73	3311
2026-10-30	AMRN	12.11	0.17	0.17	3323
2026-11-02	AMRN	12.045	0.18	3.69	3335
2026-11-03	AMRN	12.03	0.19	0.01	3392
2026-11-04	AMRN	12.26	0.19	0.22	3441
2026-11-05	AMRN	11.56	0.19	0.50	3452
2026-11-06	AMRN	11.64	0.19	0.91	3472
2026-11-09	AMRN	11.75	0.19	0.00	3508
2026-11-10	AMRN	11.75	0.19	0.05	3534
2026-11-11	AMRN	11.68	0.19	10.00	3535
2026-11-12	AMRN	11.695	0.19	0.44	3539
2026-11-13	AMRN	11.43	0.19	0.23	3548
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	AMRN	11.57	-	-	-0.07
2026-10-16	AMRN	11.32	-	-	-0.07
2026-10-19	AMRN	11.51	-	-	-0.07
2026-10-20	AMRN	11.51	-	-	-0.07
2026-10-21	AMRN	11.49	-	-	-0.07
2026-10-22	AMRN	11.58	-	-	-0.07
2026-10-23	AMRN	11.83	-	-	-0.07
2026-10-26	AMRN	12.11	-	-	-0.07
2026-10-27	AMRN	11.95	-	-	-0.07
2026-10-28	AMRN	12.76	-	-	-0.07
2026-10-29	AMRN	12.76	-	-	-0.07
2026-10-30	AMRN	12.07	-	-	-0.07
2026-11-02	AMRN	12.09	-	-	-0.04
2026-11-03	AMRN	12.02	-	-	-0.04
2026-11-04	AMRN	12.31	-	-	-0.04
2026-11-05	AMRN	11.54	-	-	-0.04
2026-11-06	AMRN	11.64	-	-	-
2026-11-09	AMRN	11.74	-	-	-
2026-11-10	AMRN	11.75	-	-	-
2026-11-11	AMRN	11.69	-	-	-
2026-11-12	AMRN	11.67	-	-	-
2026-11-13	AMRN	11.44	-	-	-
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	AMRN	0.00	0.08	2.50
2026-10-16	AMRN	0.00	0.08	2.50
2026-10-19	AMRN	0.00	0.04	2.50
2026-10-20	AMRN	0.00	0.04	2.50
2026-10-21	AMRN	0.00	0.04	2.50
2026-10-22	AMRN	0.00	0.04	2.50
2026-10-23	AMRN	0.00	0.04	2.50
2026-10-26	AMRN	0.00	0.10	2.50
2026-10-27	AMRN	0.00	0.10	2.52
2026-10-28	AMRN	0.00	0.10	2.52
2026-10-29	AMRN	0.00	0.10	2.52
2026-10-30	AMRN	0.00	0.10	2.53
2026-11-02	AMRN	0.00	0.10	2.53
2026-11-03	AMRN	0.00	0.10	2.53
2026-11-05	AMRN	0.00	0.10	2.53
2026-11-06	AMRN	0.00	0.10	2.53
2026-11-09	AMRN	0.00	-0.77	2.53
2026-11-10	AMRN	0.00	-0.77	2.53
2026-11-11	AMRN	0.00	-0.77	2.55
2026-11-12	AMRN	0.00	-0.77	2.55
2026-11-13	AMRN	0.00	-0.77	2.55
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.01

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

-0.77

Beta

0.79

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

9.63

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

87.5

Max Drawdown 5-Year %

-90.3

Target Price

P/E

Forward P/E

PEG

P/S

1.36

P/B

0.54

P/Free Cash Flow

6.39

EPS

-0.92

Average EPS Est. Cur. Y

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-10.87

Relative Volume

0.49

Return on Equity vs Sector %

-30.7

Return on Equity vs Industry %

-39

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

◆ AMRN Healthcare

$11.38

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

20/20

Pullback

13/25

Volume

11/15

Valuation

10/20

TP/AR

0/10

Options

7/10

RSI

36.7

Range 1M

6.2%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

13/30

Estimates

1/20

Inst/Vol

0/15

Options

10/10

EPS Yr

-1153.2%

EPS NY

44.3%

52W%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -3.6% upside

Quality

4/30

Valuation

3/30

Growth

12/25

Stability

6/10

LT Trend

4/5

Upside

-3.6%

Quality

MoS

-16%

AMRN — P/E HistoricalBiotechnology

Amarin Corporation plc

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 80

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

AMRN

Latest News

—

Caricamento notizie per AMRN…

stock quote shares AMRN – Amarin Corp ADR Stock Price stock today

news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025

marketwatch AMRN – Amarin Corp ADR yahoo finance google finance

stock history AMRN – Amarin Corp ADR invest stock market

stock prices AMRN premarket after hours

ticker AMRN fair value insiders trading

ALKS – Alkermes plc

ALKS — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

12.05

Margin Of Safety %

-25

Put/Call OI Ratio

0.65

EPS Next Q Diff

-0.21

EPS Last/This Y

0.08

EPS This/Next Y

-0.2

Price

47.01

Target Price

58.41

Analyst Recom

1.59

Performance Q

-5.66

Upside

-100.7%

Beta

0.28

Ticker: ALKS

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-15	ALKS	40.1	0.78	0.57	21087
2026-10-16	ALKS	41.2	0.86	12.77	20323
2026-10-19	ALKS	43	0.88	1.41	18452
2026-10-20	ALKS	44.13	0.88	0.29	18761
2026-10-21	ALKS	43.48	0.89	0.13	18798
2026-10-22	ALKS	44.18	0.89	0.06	18775
2026-10-23	ALKS	43.61	0.89	4.00	18760
2026-10-26	ALKS	44.46	0.89	20.50	18717
2026-10-27	ALKS	44.32	0.89	0.81	18718
2026-10-28	ALKS	45.26	0.90	0.06	18759
2026-10-29	ALKS	45.38	0.88	5.17	18869
2026-10-30	ALKS	45.33	0.87	0.56	19163
2026-11-02	ALKS	44.85	0.87	0.11	19169
2026-11-03	ALKS	45.66	0.87	0.19	19170
2026-11-04	ALKS	45.9	0.87	0.71	19145
2026-11-05	ALKS	44.55	0.87	0.39	19147
2026-11-06	ALKS	45.93	0.87	0.36	19148
2026-11-09	ALKS	46.15	0.87	1.09	19147
2026-11-10	ALKS	46.47	0.87	0.18	19171
2026-11-11	ALKS	47.91	0.85	0.26	19547
2026-11-12	ALKS	46.97	0.85	0.00	19565
2026-11-13	ALKS	47.02	0.65	0.06	22748
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-15	ALKS	40.09	-62.1	-	1.27
2026-10-16	ALKS	41.20	-62.1	-	1.27
2026-10-19	ALKS	43.00	-62.1	-	1.27
2026-10-20	ALKS	43.00	-62.1	-	1.27
2026-10-21	ALKS	44.13	-62.1	-	1.27
2026-10-22	ALKS	44.18	-62.1	-	1.27
2026-10-23	ALKS	43.61	-62.1	-	1.27
2026-10-26	ALKS	44.44	-62.1	-	1.27
2026-10-27	ALKS	44.33	-62.1	-	1.27
2026-10-28	ALKS	45.25	-62.1	-	1.27
2026-10-29	ALKS	45.38	-62.1	-	1.27
2026-10-30	ALKS	45.30	-62.1	-	1.27
2026-11-02	ALKS	44.85	-62.1	-	1.27
2026-11-03	ALKS	45.66	-62.1	-	1.27
2026-11-04	ALKS	45.91	-81.6	-	1.27
2026-11-05	ALKS	44.54	-81.6	-	1.27
2026-11-06	ALKS	45.92	-81.6	-	1.27
2026-11-09	ALKS	46.15	-81.6	-	1.27
2026-11-10	ALKS	46.47	-66.3	-	1.95
2026-11-11	ALKS	47.88	-100.0	-	1.55
2026-11-12	ALKS	46.97	-100.0	-	1.55
2026-11-13	ALKS	47.01	-100.0	-	1.55
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-15	ALKS	-2.49	-0.63	10.95
2026-10-16	ALKS	-2.49	-0.63	10.95
2026-10-19	ALKS	-2.49	-0.67	10.95
2026-10-20	ALKS	-2.49	-0.67	10.95
2026-10-21	ALKS	-2.49	-0.67	10.95
2026-10-22	ALKS	-2.49	-0.67	10.95
2026-10-23	ALKS	-2.49	-0.67	10.95
2026-10-26	ALKS	-2.49	-0.71	10.95
2026-10-27	ALKS	-2.49	-0.71	11.70
2026-10-28	ALKS	-2.49	-0.71	11.70
2026-10-29	ALKS	-2.49	-0.71	11.70
2026-10-30	ALKS	-2.49	-0.71	11.70
2026-11-02	ALKS	-2.31	-0.53	11.70
2026-11-03	ALKS	-2.31	-0.53	11.70
2026-11-05	ALKS	-2.31	-0.53	11.70
2026-11-06	ALKS	-2.31	-0.53	11.70
2026-11-09	ALKS	-2.31	2.29	11.68
2026-11-10	ALKS	-2.31	2.29	11.68
2026-11-11	ALKS	-2.31	2.29	12.05
2026-11-12	ALKS	-2.31	2.29	12.05
2026-11-13	ALKS	-2.31	2.29	12.05
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

0.09

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

-2.31

Institutional Transactions

2.29

Beta

0.28

Average Sales Estimate Current Quarter

459

Average Sales Estimate Next Quarter

446

Fair Value

35.29

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

15.6

Max Drawdown 5-Year %

-31.2

Target Price

58.41

P/E

Forward P/E

81.8

PEG

P/S

4.51

P/B

4.24

P/Free Cash Flow

34.76

EPS

-0.01

Average EPS Est. Cur. Y

1.55

EPS Next Y. (Est.)

1.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-0.02

Relative Volume

0.76

Return on Equity vs Sector %

-26.4

Return on Equity vs Industry %

-6.7

EPS 1 7Days Diff

0.3

EPS 1 30Days Diff

0.28

EBIT Estimation

◆ ALKS Healthcare

$47.03

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

10/20

Pullback

8/25

Volume

9/15

Valuation

12/20

TP/AR

3/10

Options

6/10

RSI

61.8

Range 1M

88.4%

Sup Dist

3.5%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

8/25

Growth

16/30

Estimates

5/20

Inst/Vol

5/15

Options

8/10

EPS Yr

-136.8%

EPS NY

209.1%

52W%

70.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🔴 SELL -2.4% upside

Quality

7/30

Valuation

1/30

Growth

13/25

Stability

6/10

LT Trend

4/5

Upside

-2.4%

Quality

MoS

-25%

ALKS — P/E HistoricalBiotechnology

Alkermes plc

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees: 2050

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder; and LUMRYZ, an extended-release oral suspension product for the treatment of cataplexy or EDS in pediatric patients. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

ALKS

Latest News

—

Caricamento notizie per ALKS…

stock quote shares ALKS – Alkermes plc Stock Price stock today

news today ALKS – Alkermes plc stock forecast ,stock prediction 2023 2024 2025

marketwatch ALKS – Alkermes plc yahoo finance google finance

stock history ALKS – Alkermes plc invest stock market

stock prices ALKS premarket after hours

ticker ALKS fair value insiders trading

No more stocks to show

SW – Smurfit WestRock plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: SW

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

MURA – Mural Oncology plc

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: MURA

No data found

No data found

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y

Last Quarter Act. EPS

Average EPS Est. Cur. Y